期刊文献+

阻塞性睡眠呼吸暂停综合征患者持续气道正压通气治疗的压力设定 被引量:8

原文传递
导出
摘要 成人OSAHS的发病率为2%~4%,睡眠结构破坏及睡眠时反复严重低氧血症可造成多系统损害。研究结果显示,OSAHS是冠心病、高血压、脑血管疾病及糖尿病的重要危险因素。持续气道正压通气(continuous positive airway pressure,CPAP)是目前公认的最有效的治疗手段,可减少OSAHS患者日间嗜睡症状,提高生活质量,长期治疗可减低心脑血管并发症和病死率。CPAP治疗的有效性与其设置的治疗压力有关,压力过低难以达到疗效,压力过高可能影响治疗的依从性。
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2010年第2期146-148,共3页 Chinese Journal of Tuberculosis and Respiratory Diseases
  • 相关文献

参考文献13

  • 1Young T, Palta M, Dempsey J, et al. The occurrence of sleep- disordered breathing among middle-aged adults. N Engl J Med, 1993, 328: 1230-1235.
  • 2张文莉,王士雯,卢才义,刘鹏,季鲜,赵玉生.冠心病的危险因素-睡眠呼吸暂停[J].中国现代医学杂志,2003,13(17):4-6. 被引量:11
  • 3张希龙,殷凯生,王虹,贾恩志,杨玉.阻塞性睡眠呼吸暂停低通气综合征与代谢综合征相关机制的探讨[J].中华结核和呼吸杂志,2004,27(9):647-648. 被引量:15
  • 4中华医学会呼吸病学分会睡眠呼吸疾病学组.阻塞性睡眠呼吸暂停低通气综合征诊治指南(草案)[J].中华结核和呼吸杂志,2002,25(4):195-198. 被引量:1845
  • 5Stradling JR, Barbour C, Pitson DJ, et al. Automatic nasal continuous positive airway pressure titration in the laboratory patient outcomes. Thorax, 1997, 52:72-75.
  • 6Miljeteig H, Hoffistein V. Determinants of continuous positive airway pressure level for treatment of obstructive sleep apnea. Am Rev Respir Dis, 1993, 147 (6 Pt 1):1526-1530.
  • 7Stauffer JL, Byucj MK, Bixler EO, et al. Morphology of the uvula in obstructive sleep apnea. Am Rev Respir Dis, 1989, 140:724- 728.
  • 8Vgontzas AN, Tan TL, Bixler EO, et al. Sleep apnea and sleep disruption in obese patients. Arch Intern Med, 1994, 154:1705- 1711.
  • 9李庆云,万欢英,李敏,刘嘉琳,倪瑾华,曹蓓,温弗乐,黄绍光.CPAP治疗OSAHS压力滴定方式选择-A、B还是C?[J].临床肺科杂志,2007,12(6):597-599. 被引量:5
  • 10Kessler R, Weitzenblum E, Chaouat A, et al. Evaluation of unattended automated titration to determine therapeutic continuous positive airway pressure in patients with obstructive sleep apnea. Chest, 2003, 123 : 704-710.

二级参考文献29

  • 1Young T, Palta M, Dempsey J, et al. The occurrence of sleep -disordered breathing among middle- aged adults. N Engl J Med,1993; 328:1230-1235.
  • 2Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med, 1996; 154:279-289.
  • 3He J, Kryger MH, Zorick FJ, et al. Mortality and apnea index in obstructive sleep apnea. Chest, 1988; 94:9 - 14.
  • 4Koskenvuo M, Kapiro J, Telakivi, et al. Snoring as a risk factor for ischaemic heart disease and stroke in men. Br Meal J, 1987; 294:16-19.
  • 5Mooe T, Rabben T, Wiklund U, et al. Sleep- disordered breathing in men with coronary artery disease. Chest, 1996; 109:659-663.
  • 6Hung J, Whitford EG, Parsons RW, et al. Association of sleep apnoea with myocardial infarction in men. Lancet, 1990; 336:261-264.
  • 7Weiss JW, Remsburg S, Garpested E, et al. Hemodynarnic consequences of obstructive bleep apnea. Sleep, 1996; 19:388-397.
  • 8Dean RT, Wwilcox I. Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep, 1993; 16(suppl 8): 15-21.
  • 9Franklin KA, Nilsson JB, Sahlin C, et al. sleep apnoea and nocturnal angina. Lancet, 1995;345:1085-1087.
  • 10Weiss JW, Remsburg S, Garpestad E, et el. Hemodynarnic consequences of obstructive sleep apnea. Sleep, 1996; 19:388-397.

共引文献1862

同被引文献102

引证文献8

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部